Personal Lab Offers Rapid Detection of Food Allergens
By LabMedica International staff writers Posted on 06 Nov 2017 |

Image: The iEAT system for onsite antigen detection consists of a pocket-sized detector, an electrode chip, and a disposable kit for allergen extraction. The detector connects with a smartphone for system control and data upload to a cloud server (Photo courtesy of Lin, et al. ACS Nano, August 2017).
Researchers have developed a small, low cost device for individual use that can accurately detect food allergens in less than ten minutes.
Adverse food reactions, including food allergies, food sensitivities, and autoimmune reaction (e.g., celiac disease) affect 5-15% of the population of the USA and remain a considerable public health problem requiring stringent food avoidance and epinephrine availability for emergency events. Avoiding problematic foods is difficult in practical terms, given current reliance on prepared foods and out-of-home meals.
In response to the food allergy problem, investigators at Harvard Medical School (Boston, MA, USA) developed a portable, point-of-use detection technology, that they called "integrated exogenous antigen testing" (iEAT).
The iEAT device consists of three components: (1) a small plastic test tube, (2) a small electronic detection module, and (3) the electronic keychain reader. To perform the test, the user dissolves a small sample of the food in the plastic test tube and then adds magnetic beads that capture the food allergen of interest. A bit of this mixture is loaded onto electrode strips attached to a small module that is then inserted into the electronic keychain reader. The keychain reader has a small display that indicates whether the allergen is present, and if so, in what concentration.
The prototype iEAT system was optimized to detect five major food antigens in peanuts, hazelnuts, wheat, milk, and eggs. Antigen extraction and detection with iEAT required less than 10 minutes and achieved high-detection sensitivities (e.g., 0.1 milligram per kilogram for gluten, 200 times lower than regulatory limits of 20 milligram per kilogram).
The investigators also developed a dedicated cell phone application, which allows the user to compile and store the data collected by testing different foods for various allergens at different restaurants or in packaged foods. The application is set up to share this information online with both time and location stamps indicating when, where, and in what food or dish an allergen reading was taken.
“High accuracy built into a compact system was the key goals of the project,” said contributing author Dr. Ralph Weissleder, professor of radiology and systems biology at Harvard Medical School. “Users can be confident that even if they are sensitive to very low levels, iEAT will be able to give them exact concentrations. Armed with accurate concentration levels they will not have to completely avoid potentially problematic foods, but will know whether an allergen is at a dangerous level for them or a concentration that is safe for them to eat.”
The iEAT device was described in the August 2017 issue of the journal ACS Nano.
Related Links:
Harvard Medical School
Adverse food reactions, including food allergies, food sensitivities, and autoimmune reaction (e.g., celiac disease) affect 5-15% of the population of the USA and remain a considerable public health problem requiring stringent food avoidance and epinephrine availability for emergency events. Avoiding problematic foods is difficult in practical terms, given current reliance on prepared foods and out-of-home meals.
In response to the food allergy problem, investigators at Harvard Medical School (Boston, MA, USA) developed a portable, point-of-use detection technology, that they called "integrated exogenous antigen testing" (iEAT).
The iEAT device consists of three components: (1) a small plastic test tube, (2) a small electronic detection module, and (3) the electronic keychain reader. To perform the test, the user dissolves a small sample of the food in the plastic test tube and then adds magnetic beads that capture the food allergen of interest. A bit of this mixture is loaded onto electrode strips attached to a small module that is then inserted into the electronic keychain reader. The keychain reader has a small display that indicates whether the allergen is present, and if so, in what concentration.
The prototype iEAT system was optimized to detect five major food antigens in peanuts, hazelnuts, wheat, milk, and eggs. Antigen extraction and detection with iEAT required less than 10 minutes and achieved high-detection sensitivities (e.g., 0.1 milligram per kilogram for gluten, 200 times lower than regulatory limits of 20 milligram per kilogram).
The investigators also developed a dedicated cell phone application, which allows the user to compile and store the data collected by testing different foods for various allergens at different restaurants or in packaged foods. The application is set up to share this information online with both time and location stamps indicating when, where, and in what food or dish an allergen reading was taken.
“High accuracy built into a compact system was the key goals of the project,” said contributing author Dr. Ralph Weissleder, professor of radiology and systems biology at Harvard Medical School. “Users can be confident that even if they are sensitive to very low levels, iEAT will be able to give them exact concentrations. Armed with accurate concentration levels they will not have to completely avoid potentially problematic foods, but will know whether an allergen is at a dangerous level for them or a concentration that is safe for them to eat.”
The iEAT device was described in the August 2017 issue of the journal ACS Nano.
Related Links:
Harvard Medical School
Latest Technology News
- New POC Biosensing Technology Improves Detection of Molecular Biomarkers
- Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
- AI-Assisted Non-DNA Based Test Identifies Viral Infections in Minutes
- AI Method Predicts Overall Survival Rate of Prostate Cancer Patients
- Breath Test to Enable Early Detection of Breast Cancer
- First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels
- Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more